Trump announces deal with Pfizer to lower drug prices, including 'TrumpRx' website

President Donald Trump announced Tuesday that his administration has reached a deal with Pfizer for it to voluntarily sell its drugs at lower prices to Medicaid patients.

President Donald Trump announced Tuesday that his administration has reached a deal with Pfizer for it to voluntarily sell its drugs at lower prices to Medicaid patients.

As part of the deal, Trump said, Pfizer will sell some of its drugs on a new “direct to consumer” website called “TrumpRx.” Trump said the website would be operated by the federal government, but offered few details about how the program would work.

The deal Pfizer cut with the White House will give the company a three-year grace period on Trump’s planned tariffs on pharmaceuticals made abroad, which are expected to take effect Wednesday.

The agreement on lower prices will cover “a large majority” of Pfizer's primary care medicines, along with speciality brand-name drugs, which will be offered at discounts averaging 50% and reaching as high as 85%, a spokesperson for the company said.

That includes Pfizer’s menopause drug Duavee, which will be available for as little as $30 — an 85% reduction, the spokesperson said. The overactive bladder drug Toviaz will drop 85% to $42, while its skin ointment Eucrisa will see an 80% cut to $162.